Acquisition Completed

Sensei Biotherapeutics acquisition of Faeth Therapeutics

Announced 18 Feb 2026 · NASDAQ: FTH

Advisers

Faeth Therapeutics

Target

Legal adviser

Sensei Biotherapeutics

Acquirer

Financial adviser
Legal adviser
Target
Faeth Therapeutics
Acquirer
Sensei Biotherapeutics
Target based in
United States
Buyer based in
United States
Completed
18 Feb 2026
Sector
Biotech
Tags
Biotech, Oncology, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.